D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE ...

He co-founded and serves as CEO of Iambic Therapeutics, a biotechnology company that is disrupting ... for use in diagnosing and treating diseases, in and outside of the United States. Forward-looking ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly effective, and convenient once-daily oral JAK ...

U.S. Food and Drug Administration approves Zenrelia, a once-daily oral JAK inhibitor for dogs with allergic and atopic ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Dr. Roger Jeffs, Ph.D., Chief Executive Officer of Liquidia, stated: “We are pleased with the court’s decision to find United Therapeutics liable for its interference with the launch of generic ...

United Therapeutics Corporation (UTHR) stock saw a modest uptick, ending the day at $353 which represents a slight increase of $1.67 or 0.48% from the prior close of $351.33. The stock opened at $349.

The "United Kingdom Monkeypox Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.United Kingdom Monkeypox ...

MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with rare ...

Liquidia said a U.S. court determined losses caused by interference from United Therapeutics during the launch of its generic Treprostinil Injection were in excess of $137 million.